Evidence map›Paper›PMID 29429058›Full record

ArticleMedical oncology (Northwood, London, England)2018

Immunosuppressive monocytes (CD14

D S Lima, R P G Lemes, D M Matos

Abstract read
PubMed Publisher
In one paragraph

Article in Medical oncology (Northwood, London, England), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Trial
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

D S LimaOncohematology Section, Albert Sabin Children Hospital, Ceará, Brazil.
R P G LemesDepartment of Clinical and Toxicological Analysis, Federal University of Ceará, UFC, Ceará, Brazil.
D M MatosFlow Cytometry Section, Clementino Fraga Laboratory, Ceará, Brazil. dmazza@alumni.usp.br.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In tumor microenvironment, immunosuppression is a common event and results from the inhibition of activated immune cells and generation of cells with immunosuppressive capacity, as some subtypes of monocytes. The aim of this study was to evaluate the presence of immunosuppressive CD14

Indexed as

Induction ChemotherapyAdolescentAntineoplastic Combined Chemotherapy ProtocolsChildChild, PreschoolFemaleFollow-Up StudiesHLA-DR AntigensHumansImmunosuppression TherapyInfantLipopolysaccharide ReceptorsMaleMonocytesPrecursor B-Cell Lymphoblastic Leukemia-LymphomaPrognosisHLA-DR AntigensLipopolysaccharide ReceptorsAcute lymphoblastic leukemiaFlow cytometryImmunosuppressive monocytes

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.